Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Havranek

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Biomolecular Structure & Dynamics|June 17, 2020
An <i>in silico</i> approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main proteaseBrandon Havranek, Shahidul M Islam
Journal of Biomolecular Structure & Dynamics|August 14, 2020
Prediction and evaluation of deleterious and disease causing non-synonymous SNPs (nsSNPs) in human NF2 gene responsible for neurofibromatosis type 2 (NF2)Brandon Havranek, Shahidul M Islam
Proteins|July 21, 2021
In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs diseaseAhmad Almanasra, Brandon Havranek, Shahidul M Islam
The Journal of Physical Chemistry. B|February 21, 2020
New Insights into the Role of Hydrogen Bonding in Furanoside Binding to ProteinShahidul M Islam, Brandon Havranek, Zahin Ibnat, et al.
Proteins|January 25, 2021
In silico screening and molecular dynamics simulation of deleterious PAH mutations responsible for phenylketonuria genetic disorderAndrea Lopez, Brandon Havranek, George A Papadantonakis, et al.
Scientific Reports|February 10, 2025
Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomesBrandon Havranek, Rebecca Loh, Beatriz Torre, et al.
Current Clinical Microbiology Reports|November 19, 2024
SARS-CoV-2 Resistance to Small Molecule InhibitorsUxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, et al.
Journal of Chemical Information and Modeling|August 24, 2021
Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar AffinityBrandon Havranek, Kui K Chan, Austin Wu, et al.
Journal of Chemical Information and Modeling|November 10, 2023
Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental ApproachBrandon Havranek, Robel Demissie, Hyun Lee, et al.
Communications Biology|May 12, 2023
A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivoBrandon Havranek, Graeme Walker Lindsey, Yusuke Higuchi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Structure & Dynamics|June 17, 2020
An <i>in silico</i> approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main proteaseBrandon Havranek, Shahidul M Islam
Journal of Biomolecular Structure & Dynamics|August 14, 2020
Prediction and evaluation of deleterious and disease causing non-synonymous SNPs (nsSNPs) in human NF2 gene responsible for neurofibromatosis type 2 (NF2)Brandon Havranek, Shahidul M Islam
Proteins|July 21, 2021
In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs diseaseAhmad Almanasra, Brandon Havranek, Shahidul M Islam
The Journal of Physical Chemistry. B|February 21, 2020
New Insights into the Role of Hydrogen Bonding in Furanoside Binding to ProteinShahidul M Islam, Brandon Havranek, Zahin Ibnat, et al.
Proteins|January 25, 2021
In silico screening and molecular dynamics simulation of deleterious PAH mutations responsible for phenylketonuria genetic disorderAndrea Lopez, Brandon Havranek, George A Papadantonakis, et al.
Scientific Reports|February 10, 2025
Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomesBrandon Havranek, Rebecca Loh, Beatriz Torre, et al.
Current Clinical Microbiology Reports|November 19, 2024
SARS-CoV-2 Resistance to Small Molecule InhibitorsUxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, et al.
Journal of Chemical Information and Modeling|August 24, 2021
Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar AffinityBrandon Havranek, Kui K Chan, Austin Wu, et al.
Journal of Chemical Information and Modeling|November 10, 2023
Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental ApproachBrandon Havranek, Robel Demissie, Hyun Lee, et al.
Communications Biology|May 12, 2023
A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivoBrandon Havranek, Graeme Walker Lindsey, Yusuke Higuchi, et al.
Pageof 2